Last Updated on December 31, 2023 by The Health Master
A top company official has said that Dr. Reddy’s Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register the Sputnik Light vaccine as a booster dose against C-19.
The Hyderabad-based drug major had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and distribute the vaccine in India in September 2020.
Last year, the company received permission from the DCGI to import the Sputnik vaccine into India for restricted use in emergency situations in April.
“As regards to Sputnik, we are now ready with capacities in India. We are working actively with the government of India to register Sputnik Light as a vaccine and as a booster dose of Sputnik V, ” Dr Reddy’s Laboratories CEO Erez Israeli said in an analyst call.
The drug maker has also submitted a proposal to DCGI to conduct a trial to test Sputnik Light as a booster to other vaccines, he added.
“Sputnik continues to be a viable option for Dr Reddy’s for India and other countries,” Israeli stated.
He noted that the company will have to get approval from the Indian authorities for the protocol of the trial.
“And pending that approval of that protocol, we will have a trial with other vaccines so it will serve as another option both private as well as the government for the booster in the future. We believe that the boosters will be part of our life and we’ll have to take it once or twice a year now,” Israeli said.
On exports, he noted that there were no restrictions on the overseas shipment of the vaccine.
“We can export the products, both the vaccine as well as the other products,” Israeli stated.
Dr Reddy’s has already launched molnupiravir in the country, expanding its portfolio to fight against the on-going C-19 pandemic, Israeli noted.
“We are also working on certain export opportunities in line with the licensing rights obtained from Merck,” he added.
Isopropyl Alcohol IP will uplift the prestige of the Pharma sector
CSIR bone health drug to be developed in US
Govt to include Acitretin in Schedule H of Drugs Rules, 1945
DoP revises list of Medical Devices for which no local manufacturers…
Stop use of Kanamycin injection: TB activists
IPC to develop & revise IP general chapters, Monographs
USFDA gives nod to Granules India for generic antidepressant drug
NPPA extends trade margin capping on these 5 Medical Devices
Pharma Companies to pay $590 mn to US Native Americans over opioids
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
